Medifast Inc

Medifast Inc

MED

Get informed when a big investor buys or sells

+ Follow
Market Cap$140.32M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medifast IncMedifast Inc-5.4--13%0.40.2
$41.67

Current Fair Value

263% upside

Undervalued by 263% based on the discounted cash flow analysis.

Share Statistics

Market cap$140.32 Million
Enterprise Value$101.29 Million
Dividend Yield$6.59 (-)
Earnings per Share$-1.7
Beta0.68
Outstanding Shares11,135,000

Return

Return on Equity-13.04%ROE
Return on Assets-9.83%
Return on Invested Capital-7.30%

Valuation & Multiples

P/E Ratio-5.42P/E Ratio
PEG2.41PEG
Price to Sales0.41Price to Sales
Price to Book Ratio0.68Price to Book Ratio
Enterprise Value to Revenue0.32
Enterprise Value to EBIT-6.34
Enterprise Value to Net Income-4
Total Debt to Enterprise0.32
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 3, 2026
EPS Estimate
$-0.65
Average shareholder expectation
Revenue Estimate
$72.70 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$-0.35
Average shareholder expectation
Revenue Estimate
$71.30 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0128 2.23%
Total Calls125,200 92.17%
Total Puts1,600 97.15%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %11.85% 66.31%
Total Invested$13.84M 84.20%
Investors Holding41 79.00%

ESG Score

No data

About Medifast Inc

550 employees
CEO: Daniel Chard

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...